Citadel Advisors’s Envoy Medical COCH Stock Holding History
Bought
Maintained
Sold
Other funds holding COCH
Citadel Advisors's COCH Position: Q3 2026 in Review
Citadel Advisors opened a new position in Envoy Medical (COCH) in Q3 2026: 2,828 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #13700 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in COCH as recently as Q4 2025.
Citadel Advisors first reported a position in COCH in Q3 2021 and has held it in 10 quarters since. The position peaked at $5.05M in Q4 2022. 33 funds tracked by Wall St. Rank hold COCH as of Q3 2026.
- Citadel Advisors held 2,828 shares of Envoy Medical worth $19.3K as of Q3 2026.
- Envoy Medical was a new Citadel Advisors position in Q3 2026.
- Envoy Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13700 holding.
- Citadel Advisors first reported a position in Envoy Medical in Q3 2021 and has held it in 10 quarters since.
- Citadel Advisors's Envoy Medical position peaked at $5.05M in Q4 2022.
- 33 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.